- Filed
- Apr 29, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · Apr 27, 2021 | 54.43M sh |
| Long Term Debt | Q1 2021 · Mar 31, 2021 | $7.65M |
| Long Term Debt | Q1 2021 · Dec 31, 2020 | $0 |
| Short Term Debt | Q1 2021 · Mar 31, 2021 | $2M |
| Short Term Debt | Q1 2021 · Dec 31, 2020 | $13.86M |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $66.04M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $79.77M |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $11.42M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $25M |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $82.18M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $89.51M |
| Current Assets | Q1 2021 · Mar 31, 2021 | $68.82M |
| Current Assets | Q1 2021 · Dec 31, 2020 | $82.23M |
| Total Assets | Q1 2021 · Mar 31, 2021 | $83.94M |
| Total Assets | Q1 2021 · Dec 31, 2020 | $98.49M |
| Shares Diluted | Q1 2021 · Mar 31, 2020 | 28.14M sh |
| Capex | Q1 2021 · Mar 31, 2020 | $233K |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | −$13.8M |
| Stockholders Equity | Q1 2021 · Mar 31, 2020 | $13.01M |
| Stockholders Equity | Q1 2021 · Dec 31, 2019 | $25.04M |
| Eps Diluted | Q1 2021 · Mar 31, 2020 | −$0.46 |
| Eps Basic | Q1 2021 · Mar 31, 2020 | −$0.46 |
| Sga Expense | Q1 2021 · Mar 31, 2020 | $3.39M |
| Rd Expense | Q1 2021 · Mar 31, 2020 | $9.99M |
| Net Income | Q1 2021 · Mar 31, 2020 | −$12.85M |
| Operating Income | Q1 2021 · Mar 31, 2020 | −$13.38M |